Welcome to MCL!

This is the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions.

The MCL Consortium consists of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.




MCL 6th Semiannual Steering Committee Meeting

The MCL Consortium will hold its 6th Face-to-Face Steering Committee Meeting in Baltimore at Johns Hopkins University October 10 - 12, 2018.